Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous oxide for prevention of postoperative nausea and vomiting after rhinoplasty
IRCT20240508061708N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nitrous oxide in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Incidence and severity of postoperative nausea and vomiting in recovery and Incidence and severity of postoperative nausea and vomiting within 24 hours after surgery. Started Dec 2024; status: completed.
02
Drugs
nitrous oxide
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20240508061708N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240508061708N1.